Rifabutin 10135-0738
Product NDC
10135-0738- Manufacturer
- Marlex Pharmaceuticals, Inc.
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- May 1, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA215041
Need to source Rifabutin? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Rifabutin | 150 mg/1 |
Drug Class
Rifamycin Antimycobacterial [EPC]Rifamycin Antimycobacterial [EPC]Rifamycins [CS]
Packaging Options(1)
100 CAPSULE in 1 BOTTLE (10135-738-01)